high - Advertising spending is highly discretionary and correlates 1.2-1.5x with GDP growth. During recessions, marketing budgets are typically first to be cut (10-30% declines in 2008-2009, 5-15% in 2020), with recovery lagging GDP by 2-4 quarters. Consumer-facing clients (CPG, retail, automotive) representing 50%+ of revenue are particularly cyclical, while healthcare and technology verticals provide relative stability.

Rising rates create moderate headwinds through three channels: (1) higher debt service costs on $1.4B net debt (estimated $50-70M annual interest expense sensitivity to 100bps rate move), (2) reduced client advertising budgets as corporate financing costs increase and growth investments are deferred, and (3) valuation multiple compression as investors rotate from growth to value. However, variable-rate debt exposure is partially hedged, and strong FCF generation enables deleveraging.

value - Stock trades at 0.4x P/S and 8.1x EV/EBITDA, well below historical agency multiples (12-15x) and peers, attracting contrarian investors betting on post-merger integration success and margin normalization. Turnaround thesis appeals to deep-value funds willing to wait 2-3 years for synergy realization. Limited institutional ownership and -24% 1-year return create opportunity for patient capital, but lack of dividend (0.1% net margin) and growth uncertainty deter income and momentum investors.